Xiaoling Wang

962 total citations
62 papers, 699 citations indexed

About

Xiaoling Wang is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Xiaoling Wang has authored 62 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 24 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Xiaoling Wang's work include Pancreatic and Hepatic Oncology Research (6 papers), Esophageal Cancer Research and Treatment (6 papers) and Metal complexes synthesis and properties (5 papers). Xiaoling Wang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Esophageal Cancer Research and Treatment (6 papers) and Metal complexes synthesis and properties (5 papers). Xiaoling Wang collaborates with scholars based in China, United States and Malaysia. Xiaoling Wang's co-authors include Zhanjun Guo, Cui-ju Wang, Ruixing Zhang, Zhong‐Lu You, Baoen Shan, Da‐Hua Shi, Xiaofang Li, Yue Zhao, Lin Zhang and Ping Wang and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Xiaoling Wang

60 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Wang China 15 299 232 130 84 74 62 699
Lei Deng China 4 299 1.0× 236 1.0× 185 1.4× 55 0.7× 90 1.2× 10 691
Xiao‐Hui Zheng China 16 537 1.8× 260 1.1× 294 2.3× 50 0.6× 88 1.2× 58 933
Soon-Cen Huang Taiwan 13 372 1.2× 141 0.6× 154 1.2× 125 1.5× 67 0.9× 19 730
Elena Bevilacqua United States 18 617 2.1× 157 0.7× 115 0.9× 101 1.2× 48 0.6× 24 1.0k
Benjamin J. Blyth Australia 18 268 0.9× 181 0.8× 151 1.2× 39 0.5× 363 4.9× 59 921
Eva Morán Italy 12 374 1.3× 182 0.8× 73 0.6× 120 1.4× 15 0.2× 18 766
Gregory Dyson United States 20 577 1.9× 304 1.3× 326 2.5× 160 1.9× 142 1.9× 74 1.1k
Guoliang Xu China 17 602 2.0× 266 1.1× 116 0.9× 157 1.9× 184 2.5× 34 1.5k
Weiwei Li China 14 281 0.9× 227 1.0× 106 0.8× 34 0.4× 96 1.3× 44 631

Countries citing papers authored by Xiaoling Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wang more than expected).

Fields of papers citing papers by Xiaoling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wang. The network helps show where Xiaoling Wang may publish in the future.

Co-authorship network of co-authors of Xiaoling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Wang. A scholar is included among the top collaborators of Xiaoling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Wang. Xiaoling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Xiaoling, et al.. (2025). Conditional GAN performs better than orthopedic surgeon in virtual reduction of femoral neck fracture. BMC Musculoskeletal Disorders. 26(1). 687–687. 1 indexed citations
3.
Wang, Chenwei, Jiewen Chen, Jingyao Li, et al.. (2024). An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model. Journal of Clinical Investigation. 134(8). 3 indexed citations
4.
Chen, Zhen‐Yu, et al.. (2022). Ficolin-2: A potential immune-related therapeutic target with low expression in liver cancer. Frontiers in Oncology. 12. 987481–987481. 2 indexed citations
5.
6.
Stabellini, Nickolas, Jennifer Cullen, Justin X. Moore, et al.. (2022). Abstract 10355: Allostatic Load and Cardiovascular Outcomes in Males With Prostate Cancer. Circulation. 146(Suppl_1). 1 indexed citations
7.
Zhou, Jianying, et al.. (2020). Mechanism of Acquired Resistance to Nivolumab in Lung Squamous Cell Carcinoma: Case Report and Review of the Literature. Immunotherapy. 12(13). 957–964. 6 indexed citations
8.
Wang, Xiaoling, Xiaodong Teng, Wei Ding, Ke Sun, & Bo Wang. (2020). A clinicopathological study of 30 breast cancer cases with a HER2/CEP17 ratio of ≥2.0 but an average HER2 copy number of <4.0 signals per cell. Modern Pathology. 33(8). 1557–1562. 8 indexed citations
9.
Xu, Liming, Qihan You, Xiaoling Wang, et al.. (2020). Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples. BMC Cancer. 20(1). 344–344. 17 indexed citations
10.
Deng, Huiyan, Chang Liu, Guoliang Zhang, Xiaoling Wang, & Yueping Liu. (2018). Lung adenocarcinoma with concurrent ALK and ROS1 rearrangement: A case report and review of the literatures. Pathology - Research and Practice. 214(12). 2103–2105. 6 indexed citations
11.
Lu, Guangjun, et al.. (2017). Clinical efficacy of spleen-preserving distal pancreatectomy with or without splenic vessel preservation. Medicine. 96(48). e8600–e8600. 4 indexed citations
12.
Li, Yong, et al.. (2017). Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms. Oncology Letters. 13(4). 2391–2396. 7 indexed citations
13.
Yin, Fei, et al.. (2016). Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. World Journal of Gastroenterology. 22(9). 2837–2837. 27 indexed citations
14.
Zhao, Yue, et al.. (2013). Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer. Annals of Diagnostic Pathology. 17(6). 483–485. 41 indexed citations
15.
16.
Li, Shengmian, Xiaoling Wang, Huijing Zhang, et al.. (2011). 8-Hydroxy-2′-deoxyguanosine expression predicts hepatocellular carcinoma outcome. Oncology Letters. 3(2). 338–342. 18 indexed citations
17.
Zhou, Tao, Yang Li, Guoming Ma, et al.. (2009). [Clinicopathologic features and prognosis of triple negative breast cancer].. PubMed. 89(32). 2261–4. 8 indexed citations
18.
Ma, Li, Xianghong Zhang, Lei Xing, et al.. (2008). [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].. PubMed. 30(4). 279–83. 8 indexed citations
19.
Pan, Xiaolin, Lili Zheng, Xiaoling Wang, et al.. (2008). Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China. European Journal of Cancer Prevention. 17(5). 460–466. 10 indexed citations
20.
Wang, Ping, Xiaohua Wu, Wenxue Chen, Jin Liu, & Xiaoling Wang. (2007). The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms. Gynecologic Oncology. 104(3). 714–720. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Deng Breakdown of academic impact, for papers by Xiao‐Hui Zheng Breakdown of academic impact, for papers by Soon-Cen Huang Breakdown of academic impact, for papers by Elena Bevilacqua Breakdown of academic impact, for papers by Benjamin J. Blyth Breakdown of academic impact, for papers by Eva Morán Breakdown of academic impact, for papers by Gregory Dyson Breakdown of academic impact, for papers by Guoliang Xu Breakdown of academic impact, for papers by Weiwei Li
Rankless by CCL
2026